Themis Medicare (BOM:530199) 5-Year Yield-on-Cost %: 0.90 (As of Aug. 30, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530199 Themis Medicare Ltd BOM:530199
69 GF Score
Price ₹126.00
GF Value ₹141.60
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Themis Medicare 5-Year Yield-on-Cost %?

Themis Medicare BOM:530199 +0.48% 69 5-Year Yield-on-Cost % is 0.90 as of Aug. 30, 2026, which is at its 10-year median of 0.90. GuruFocus rates BOM:530199 with a GF Score™ of 69/100 and a GF Value™ of ₹141.60 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 509 Drug Manufacturers companies, Themis Medicare ranks worse than 73.08% on this metric.

Themis Medicare's yield on cost for the quarter that ended in Jun. 2026 was 0.90.


The historical rank and industry rank for Themis Medicare's 5-Year Yield-on-Cost % or its related term are showing as below:

BOM:530199' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.34   Med: 0.9   Max: 1.63
Current: 0.9


During the past 13 years, Themis Medicare's highest Yield on Cost was 1.63. The lowest was 0.34. And the median was 0.90.


BOM:530199's 5-Year Yield-on-Cost % is ranked worse than
73.08% of 509 companies
in the Drug Manufacturers industry
Industry Median: 2.37 vs BOM:530199: 0.90

Themis Medicare  (BOM:530199) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Themis Medicare 5-Year Yield-on-Cost % Related Terms


BOM:530199 vs ZTS: 5-Year Yield-on-Cost % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Themis Medicare's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Themis Medicare 5-Year Yield-on-Cost % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Themis Medicare's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Themis Medicare's 5-Year Yield-on-Cost % falls into.


BOM:530199
69GF Score
Themis Medicare Ltd BOM:530199
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Themis Medicare 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Themis Medicare is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.90 mean?
Themis Medicare (BOM:530199) has a 5-Year Yield-on-Cost % of 0.90 as of Aug. 30, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Themis Medicare and its competitors. This is near median its historical median of 0.90. Over the past decade, Themis Medicare's 5-Year Yield-on-Cost % has ranged from 0.34 to 1.63. According to the industry distribution chart, Themis Medicare ranks #372 out of 509 companies in the Drug Manufacturers industry, placing it in the top 73.1%.
Is Themis Medicare's 5-Year Yield-on-Cost % too high?
Themis Medicare's current 5-Year Yield-on-Cost % of 0.90 is near median its 10-year median of 0.90. Over the past 10 years, this metric has ranged from a low of 0.34 to a high of 1.63. The Drug Manufacturers industry median 5-Year Yield-on-Cost % is 2.37. Themis Medicare's value of 0.90 is 62% below this industry median. Based on the distribution chart, Themis Medicare ranks #372 out of 509 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Themis Medicare has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Themis Medicare's 5-Year Yield-on-Cost % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Themis Medicare ranks #372 out of 509 companies for 5-Year Yield-on-Cost %. This places Themis Medicare in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.37. Themis Medicare's value of 0.90 is 62% below this benchmark. Historically, Themis Medicare's own 5-Year Yield-on-Cost % has ranged from 0.34 to 1.63 over the past decade. While the company's 10-year median is 0.90 vs. the industry median of 2.37, Themis Medicare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.37, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Themis Medicare's current 5-Year Yield-on-Cost % of 0.90 is 62% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Themis Medicare and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Themis Medicare's current 5-Year Yield-on-Cost % is 0.90, which is near median its own 10-year median of 0.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Themis Medicare stock overvalued right now?
Based on GuruFocus' analysis, Themis Medicare (BOM:530199) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹141.60, compared to a current price of ₹126.00 — trading 11% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.90, which is near median its 10-year median of 0.90 and 62% below the Drug Manufacturers industry median of 2.37. Themis Medicare's overall GF Score™ is 69/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Themis Medicare (BOM:530199), the current 5-Year Yield-on-Cost % is 0.90 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Themis Medicare (BOM:530199) Overvalued in 2026?

Based on GuruFocus' analysis, Themis Medicare stock appears to be undervalued. The current stock price of ₹126.00 is trading 11% below its estimated GF Value™ of ₹141.60. GuruFocus considers Themis Medicare to be Modestly Undervalued.

Key valuation signals for BOM:530199:

  • 5-Year Yield-on-Cost %: 0.90 (near median its 10-year median of 0.90)
  • GF Value™: ₹141.60 vs. price of ₹126.00 (11% below fair value)
  • GF Score™: 69/100 with 7 warning signs
  • Industry Position: 62% below the Drug Manufacturers median (#372 of 509)

No single metric tells the full story. See the BOM:530199 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Themis Medicare Business Description

Other Exchanges THEMISMED:India
Address Swami Vivekanand Road, 11/12, Udyog Nagar Industrial Estate, Goregaon (West), Mumbai, MH, IND, 400 104
Themis Medicare Ltd is an Indian based company engaged in the manufacturing and marketing of pharmaceutical products. The Company operates only in one business segment which is Pharmaceuticals. Geographically, it derives a majority of revenue from India and also has a presence in the international market. Its product categories include Anti Malarial, CCD products, Nutritional Gummies, and Candy and Other Products such as OD-LM, Dexem, Medzol and Tazowin.
69GF Score

Get the complete analysis for BOM:530199

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹126.00
Price
₹141.60
GF Value